Subscribe to RSS
DOI: 10.1055/s-0031-1284208
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report
Publication History
Publication Date:
22 July 2011 (online)
ABSTRACT
Esthesioneuroblastoma (ENB) is an uncommon malignant tumor derived from the specialized neuroepithelium of the upper nasal cavity. The largest case series and meta-analyses suggest the combination of surgery and radiotherapy as the gold standard treatment for ENB. However, an increasing number of case series have reported excellent survival and few complications with minimally invasive endoscopic resection (MIER) in conjunction with radiotherapy of EBN in early stages of the disease. In this case report, the authors describe the first case of ENB in a young adult man who was human immunodeficiency virus (HIV)-1 and Hepatitis C virus (HCV) coinfected. The authors discuss all the aspects of this rare disease, focusing on treatment options and prognosis.
KEYWORDS
Esthesioneuroblastoma - human immunodeficiency virus-1 infection - Hepatitis C virus infection - non-acquired immunodeficiency syndrome-related cancer - treatment and prognosis
REFERENCES
- 1 Dulguerov P, Allal A S, Calcaterra T C. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001; 2 (11) 683-690
- 2 Bradley P J, Jones N S, Robertson I. Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg. 2003; 11 (2) 112-118
- 3 Diaz Jr E M, Johnigan III R H, Pero C et al.. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005; 27 (2) 138-149
- 4 Zafereo M E, Fakhri S, Prayson R et al.. Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg. 2008; 138 (4) 452-458
- 5 Jethanamest D, Morris L G, Sikora A G, Kutler D I. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007; 133 (3) 276-280
- 6 Pantanowitz L, Schlecht H P, Dezube B J. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol. 2006; 18 (5) 469-478
- 7 Chiao E Y, Krown S E. Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr Opin Oncol. 2003; 15 (5) 389-397
- 8 Cheung M C, Pantanowitz L, Dezube B J. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist. 2005; 10 (6) 412-426
- 9 Burgi A, Brodine S, Wegner S et al.. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005; 104 (7) 1505-1511
- 10 Gurtsevitch V E. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc). 2008; 73 (5) 504-513
- 11 Zignego A L, Giannini C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol. 2007; 13 (17) 2467-2478
- 12 Foote R L, Morita A, Ebersold M J et al.. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1993; 27 (4) 835-842
- 13 Levine P A, Gallagher R, Cantrell R W. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope. 1999; 109 (10) 1539-1543
Mario TumbarelloM.D.
Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore
Largo A. Gemelli 8, 00168 Roma, Italy
Email: tumbarello@rm.unicatt.it